| 32009-3 |
Cortisol.free/Creatinine |
MRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
Cortisol Free/Creatinine [Mass Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
CHEM |
|
32009-3 |
|
|
|
|
Both |
|
|
|
0 |
Cortis F/Creat 24h Ur |
|
|
|
N |
|
1 day; 17-Hydroxycorticosterone; 24 hours; 24HR; Chemistry; Compound F; Coritsol; Cort; Cortis F; CR; Crea; Creat; F; FR; hydrocortisone; Mass concentration ratio; Mass ratio; MCRto; Non-protein bound; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn |
2.73 |
2.07 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |
| 3201-1 |
Coagulation factor VII Ag |
ACnc |
PPP |
Pt |
Qn |
IA |
|
ACTIVE |
Coagulation factor VII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
3201-1 |
|
IA |
|
|
Both |
|
|
|
0 |
Fact VII Ag PPP IA-aCnc |
|
|
|
Y |
|
Antigen; Antigens; Arbitrary concentration; Coag; EIA; ELFA; ELISA; Enzyme immunoassay; F7; Fac; Fact; Fact VII; Factor 7; FVII; Hematology; Heme; IAA; MEIA; Plas; Platelet poor plasma; Point in time; Proconvertin; QNT; Quan; Quant; Quantitative; Random; Serum prothrombin conversion accelerator; SPCA; SUDS |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). |
0 |
| 32010-1 |
Diuretics |
Prid |
Ser/Plas |
Pt |
Nom |
Screen |
|
ACTIVE |
Diuretics [Identifier] in Serum or Plasma by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
32010-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Diuretics SerPl Scn |
|
|
|
N |
|
diuretic; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.19 |
2.07 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 32011-9 |
Ehrlichia sp Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Ehrlichia sp IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
32011-9 |
|
|
|
|
Both |
|
|
|
0 |
Ehrlichia IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.07 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 32012-7 |
Ehrlichia sp Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Ehrlichia sp IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
32012-7 |
|
|
|
|
Both |
|
|
|
0 |
Ehrlichia IgM Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.07 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 32013-5 |
Eosinophils/Leukocytes |
NFr |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Eosinophils/Leukocytes in Pericardial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
32013-5 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Eosinophil NFr Pcar Manual |
|
|
|
N |
|
Cardio; Cardiology; Eos; Eosin; Eosino; Eosinophil; Eosins; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Pcar; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 32014-3 |
Eosinophils/Leukocytes |
NFr |
Urine |
Pt |
Qn |
Manual count |
|
ACTIVE |
Eosinophils/Leukocytes in Urine by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
UA |
|
32014-3 |
|
Manual count |
|
|
Both |
|
|
|
0 |
Eosinophil NFr Ur Manual |
|
|
|
N |
|
Eos; Eosin; Eosino; Eosinophil; Eosins; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; Previous Releases: Order_Obs: changed from 'observation' to 'both' to reflect that the LOINC code can also be used as an order code. |
0 |
| 32015-0 |
EPINEPHrine |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
EPINEPHrine [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ng/L |
|
|
|
|
|
|
CHEM |
|
32015-0 |
|
|
|
|
Both |
|
|
|
0 |
Epineph 24h Ur-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Adrenalin; Adrenaline; Adreneline; Chemistry; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
2.07 |
|
|
|
|
|
|
|
ng/L |
|
|
|
0 |
| 32016-8 |
Glucose |
MCnc |
BldC |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Capillary blood |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
32016-8 |
|
|
|
|
Both |
|
|
|
0 |
Glucose BldC-mCnc |
|
|
|
N |
|
Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Finger stick; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders |
2.73 |
2.07 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
42 |
| 32017-6 |
Hemoglobin.other/Hemoglobin.total |
MFr |
Bld |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Hemoglobin.other/Hemoglobin.total in Blood by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
32017-6 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Hgb Other MFr Bld Elph |
|
|
|
N |
|
Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Other; Mass Fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.73 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 32018-4 |
Hepatitis A virus Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Hepatitis A virus IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
32018-4 |
|
|
|
|
Both |
|
|
|
0 |
HAV IgG Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 32019-2 |
Hepatitis B virus surface Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Hepatitis B virus surface Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
32019-2 |
|
|
|
|
Both |
|
|
|
0 |
HBV surface Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBsAg; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HBs; HBsAB; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; HepB; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Surf; Titer; Titered; Titre; Ttr |
2.75 |
2.07 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 3202-9 |
Coagulation factor VII+Acarboxy Ag |
ACnc |
PPP |
Pt |
Qn |
IA |
|
ACTIVE |
Coagulation factor VII+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
3202-9 |
|
IA |
|
|
Both |
|
|
|
0 |
Fact VII+ACA Ag PPP IA-aCnc |
|
|
|
Y |
|
Antigen; Antigens; Arbitrary concentration; Coag; EIA; ELFA; ELISA; Enzyme immunoassay; F7; Fac; Fact; Fact VII; Fact VII+ACA; Factor 7; FVII; Hematology; Heme; IAA; MEIA; Plas; Platelet poor plasma; Point in time; Proconvertin; QNT; Quan; Quant; Quantitative; Random; Serum prothrombin conversion accelerator; SPCA; SUDS |
2.69 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). |
0 |
| 32020-0 |
Homocysteine |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Homocysteine [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
32020-0 |
|
|
|
|
Both |
|
|
|
0 |
Hcys Ur-sCnc |
|
|
|
N |
|
Chemistry; Genitourinary; GU; HCY; Hcys; Hcyst; Homocyst(e)ine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; URO; Urology |
2.73 |
2.07 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 32021-8 |
HTLV I DNA |
PrThr |
Ser |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
HTLV I DNA [Presence] in Serum by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
32021-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HTLV I DNA Ser Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 32022-6 |
Hydroxyproline.free |
SCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Hydroxyproline Free [Moles/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
32022-6 |
|
|
|
|
Both |
|
|
|
0 |
OH-Proline Free 24h Ur-sCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; FR; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Non-protein bound; Ohpro; OH-Proline; OH-Proline Free; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn |
2.42 |
2.07 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 32023-4 |
Insulin-like growth factor-I |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Insulin-like growth factor-I [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
32023-4 |
|
|
|
|
Both |
|
|
|
0 |
IGF-I Bld-mCnc |
|
|
|
N |
|
Blood; Chemistry; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Sliding; Somatomedin C; Ultralente; WB; Whole blood |
2.73 |
2.07 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 32024-2 |
Magnesium |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Magnesium [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
32024-2 |
|
|
|
|
Both |
|
|
|
0 |
Magnesium 24h Ur-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Kidney; Level; MAG; Magnes; Mass concentration; Mg; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn |
2.73 |
2.07 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 32025-9 |
Malignin Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Malignin Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
32025-9 |
|
|
|
|
Both |
|
|
|
0 |
Malignin Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.56 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 32026-7 |
Observation |
Prid |
Nose |
Pt |
Nom |
Gram stain |
|
ACTIVE |
Microscopic observation [Identifier] in Nose by Gram stain |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
32026-7 |
|
Gram stain |
|
|
Both |
|
|
|
0 |
Gram Stn Nose |
|
|
|
N |
|
Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nasal; Nominal; Nos; Nose (nasal passage); Point in time; Random; Smell; St; Stains; Stn |
2.78 |
2.07 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Updated to seperate the component from the method; |
0 |
| 32027-5 |
Monocytes+Macrophages/Leukocytes |
NFr |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Monocytes+Macrophages/Leukocytes in Pericardial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
32027-5 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Monos+Macros NFr Pcar Manual |
|
|
|
N |
|
Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number Fraction; PCAR; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 32028-3 |
Monocytes+Macrophages/Leukocytes |
NFr |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Monocytes+Macrophages/Leukocytes in Pleural fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
32028-3 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Monos+Macros NFr Plr Manual |
|
|
|
N |
|
HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number Fraction; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 32029-1 |
Monocytes+Macrophages/Leukocytes |
NFr |
Periton fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Monocytes+Macrophages/Leukocytes in Peritoneal fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
32029-1 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Monos+Macros NFr Prt Manual |
|
|
|
N |
|
Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number Fraction; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 3203-7 |
Coagulation factor VII+Acarboxy Ag activity actual/Normal |
RelMCnc |
PPP |
Pt |
Qn |
IA |
|
ACTIVE |
Coagulation factor VII+Acarboxy Ag activity actual/normal in Platelet poor plasma by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
3203-7 |
|
IA |
|
|
Observation |
|
|
|
0 |
Fact VII+ACA Ag Act/Nor PPP IA |
|
|
|
Y |
|
Act/Nor; Activ; Actvty; Ag Act/Nor; Antigen; Antigens; Coag; Control; EIA; ELFA; ELISA; Enzyme immunoassay; F7; Fac; Fact; Fact VII; Fact VII+ACA; Factor 7; FVII; Hematology; Heme; IAA; MEIA; Movements; Plas; Platelet poor plasma; Point in time; Proconvertin; QNT; Quan; Quant; Quantitative; Random; Relative mass concentration; RLMCNC; Serum prothrombin conversion accelerator; SPCA; SUDS |
2.58 |
1 |
|
|
|
|
|
|
|
% |
|
|
Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). |
0 |
| 32030-9 |
Nitrate |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Nitrate [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
32030-9 |
|
|
|
|
Both |
|
|
|
0 |
Nitrate Ur Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; NO3; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
